Addressing Medicine Shortages in the EU
In an effort to combat the frequent medicine shortages experienced across its member states, the European Union has taken a significant step by publishing an initial list of 200 pharmaceutical substances deemed as “critical medicines.” This list, which is the result of a comprehensive review of 600 existing formulations, is designed to ensure a consistent supply of essential drugs and will be updated on an annual basis.
The European Union has identified 200 essential “critical medicines” to address shortages and ensure consistent supply across member states. To mitigate the issue,
The establishment of the EU’s Critical Medicines Alliance is a testament to the bloc’s commitment to resolving this issue. The Alliance serves as a consultative mechanism that includes all relevant stakeholders and focuses on transparency and methodical approaches to identify action priorities, policy solutions, and management of medicine shortages.
For smaller member states like Cyprus, which have been particularly affected by shortages due to their reliance on third-country raw materials and market size, this initiative is a welcome relief. Elena Panayiotopoulos, Cyprus’ Director of Pharmaceutical Services, highlighted the benefits of the Alliance, noting its role in ensuring that smaller markets like Cyprus are not left vulnerable to supply disruptions.
The comprehensive strategy to address critical medicines involves strengthening the EU’s own drug production capacities, creating European stockpiles, and aligning funding to effectively tackle shortages. Panayiotopoulos pointed out the importance of prioritizing medicines that are critical for treatment continuity and patient safety.
The solidarity mechanism, which is currently being piloted, has already shown promise for member states like Cyprus. Furthermore, the upcoming European Regulation ‘HTA’, set to be implemented in 2025, will provide a common clinical assessment framework that is expected to enhance access to innovative treatments and effective medications for Cypriot patients through collaborative efforts with other EU countries.
With these measures in place, the European Union is taking decisive steps towards ensuring that all its citizens have access to vital medications, thereby strengthening the healthcare infrastructure across the continent.
